Rapid increase in purchasing teams expected at CPHI North America
April 15, 2024 – Other – CPHI North America 2024, event preview
Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
12 April 2024 — Amsterdam, The Netherlands — CPHI North America (7-9 May 2024) will open at Pennsylvania Convention Center in Philadelphia, Pennsylvania, US, as the event sees a doubling of attendees across ‘purchasing and procurement’, ‘R&D’ and ‘Manufacturing’ and ‘QC/QA’. The rapid increase is attributed to both a concerted effect by Informa to attract larger buying audiences, but is also seen as a response by the US industry to macro trends – with alternative supply chains options actively being sought by both pharma and biotech companies.
“We have spent a good deal of time researching and investing resources to target these audiences in the last 12 months – in response to exhibitor feedback – but it also shows the strong desire we see among US-based companies to seek out alternative supply options and new partners. Our role is to actively help facilitate these discussions and build an ecosystem of much large networking opportunities at the event. Companies across the industry have taken note of developments that might affect supply – particularly among the largest CDMOs – and we are here to help them navigate their options and find new suppliers,” commented Sarah Griffin, manager, Pharma Brand US at Informa Markets.
The 2024 event will be the most innovative ever, with over 350 exhibitors contracted and the addition of three new engagement zones – covering sustainability, innovation and growth & development (designed to help promote job opportunities and encourage career development conversations) – alongside the first ever Start-Up Market in the US. A dedicated space where smaller innovators and enterprises from the industry can exhibit their exciting new products and solutions.
“CPHI remains at the heart of pharma in the US, and we love that we’re attracting an increasing number of industry leaders. We are seeing rising numbers of new attendees, particularly this year as we see senior executives from R&D, QC and manufacturing audiences specifically looking to re-evaluate both supply and development options,’ said Adam Andersen, Informa’s executive vice president, Pharma. He added, ‘The great thing about CPHI North America is that we’re still the only show bringing the entire US pharma supply chain together under one roof, in person, and thanks to our online event platforms our attendees and exhibitors are already making new connections ahead of the event and actively taking forward discussion to forge crucial supply chain partnerships.”
This year’s conference features 4 tracks – spanning ‘Sustainable Futures’, ‘Revolutionizing Drug Manufacturing’, ‘Supply Chain Economy’ and ‘Exploring Excipients’ – as well as a breakfast session on manufacturing excellence and the eagerly anticipated CDMO roundtable. The latter is particularly timely, with US based manufacturers in high demand in 2024. In total CPHI North American features 50+ experts spanning dozens of sessions that encompass the entire pharmaceutical development and supply chain, with seminars covering themes as varied as ‘marketing’, ‘diversity’ and ‘well-being’.
Additionally, in a further sign of pharma’s increased social responsibility, the new sustainability zone will also host a ‘commitments communication area’: where companies go to publicly pledge their goals and targets for environmental, sustainability or governance over the next few years.
To find out more about this year’s networking, the new personalised options and registration badges, please visit: www.cphi.com/northamerica/en/home.
